Abstract
Fourteen dogs, fed a regular diet and given 250 mg/kg of triton (a non-ionic surface-active agent) intravenously every 4th day, exhibited a progressively severe hyperlipemia. Serum triglycerides were the first to increase. Cholesterol, mostly in the free form, and phospholipids showed elevation only at a later stage and increased at almost identical rates. The plasma-free fatty acid concentration was from 2 to 3 times above normal. With establishment of sustained hyperlipemia, there was reduction, followed by total disappearance, of the high density D 1.063 to 1.21 lipoprotein. Most of the cholesterol and phospholipids (70 to 75 per cent of the total) were found in the D 1.006 to 1.063 lipoprotein class, the remainder in the D < 1.006 class. Triglycerides were almost evenly distributed between these two classes. The concentration of the serum lipoprotein proteins was within normal limits. All of the animals died within from 4 to 5 months after receiving the first injection of triton. Autopsy findings consistently showed: (a) numerous lipidladen macrophages in the liver, spleen, and lymph nodes; (b) significant depletion of all fat stores; (c) presence of lipids, either free or engulfed in macrophages (foam cells), in the subintima of the coronary arteries, aorta, and pulmonary arteries, indicating an early stage of atherosclerosis. Concurrent daily administration of heparin (5 mg per kilogram of body weight) did not substantially change the course of the disease. Withdrawal of triton from animals that had been receiving the detergent for from 3 to 4 months, elicited a slow return to normal of the lipid pattern. In two dogs killed when normolipemia was reestablished, all tissues were normal with the minor exception of a few hepatic macrophages still laden with sudanophilic material. It is postulated that the primary action of the injected triton was on the lipid moieties of plasma lipoproteins with formation of complexes, which, as foreign bodies, were preferentially taken up by the cells of the reticuloendothelial system. Depletion of fat stores was probably secondary to increased lipid mobilization, as an attempt by these tissues to supply energy to the parenchymal cells unable to utilize triton-bound lipids.
Full Text
The Full Text of this article is available as a PDF (1.1 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ABEL L. L., LEVY B. B., BRODIE B. B., KENDALL F. E. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952 Mar;195(1):357–366. [PubMed] [Google Scholar]
- ANDERSON N. G., FAWCETT B. An antichylomicronemic substance produced by heparin injection. Proc Soc Exp Biol Med. 1950 Aug;74(4):768–771. doi: 10.3181/00379727-74-18042. [DOI] [PubMed] [Google Scholar]
- BROWN R. K., BOYLE E., ANFINSEN C. B. The enzymatic transformation of lipoproteins. J Biol Chem. 1953 Sep;204(1):423–434. [PubMed] [Google Scholar]
- CONSTANTINIDES P., SZASZ G., HARDER F. Retardation of atheromatosis and adrenal enlargement by heparin in the rabbit. AMA Arch Pathol. 1953 Jul;56(1):36–45. [PubMed] [Google Scholar]
- DAY A. J., WILKINSON G. K., SCHWARTZ C. J., PETERS J. A. Changes in serum lipids and in aortic atherosclerosis following toluidine blue and heparin administration to cholesterol fed rabbits. Aust J Exp Biol Med Sci. 1957 Jun;35(3):277–288. doi: 10.1038/icb.1957.31. [DOI] [PubMed] [Google Scholar]
- DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FRIEDMAN M., BYERS S. O. Mechanism underlying hypercholesteremia induced by triton WR-1339. Am J Physiol. 1957 Sep;190(3):439–445. doi: 10.1152/ajplegacy.1957.190.3.439. [DOI] [PubMed] [Google Scholar]
- FRIEDMAN M., BYERS S. O. The mechanism responsible for the hypercholesteremia induced by triton WR-1339. J Exp Med. 1953 Jan;97(1):117–130. doi: 10.1084/jem.97.1.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GRAHAM D. M., LYON T. P., GOFMAN J. W., JONES H. B., YANKLEY A., SIMONTON J., WHITE S. Blood lipids and human atherosclerosis. II. The influence of heparin upon lipoprotein metabolism. Circulation. 1951 Nov;4(5):666–673. doi: 10.1161/01.cir.4.5.666. [DOI] [PubMed] [Google Scholar]
- HIRSCH R. L., KELLNER A. The pathogenesis of hyperlipemia induced by means of surface-active agents. I. Increased total body cholesterol in mice given triton WR 1339 parenterally. J Exp Med. 1956 Jul 1;104(1):1–13. doi: 10.1084/jem.104.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HORITA A., LOOMIS T. A. The influence of anticoagulants on the formation and regression of experimental atherosclerosis. J Exp Med. 1954 Oct 1;100(4):381–390. doi: 10.1084/jem.100.4.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HORLICK L., DUFF G. L. Heparin in experimental cholesterol atherosclerosis in the rabbit. I. The effect of heparin on the serum lipids, and development of atherosclerosis. AMA Arch Pathol. 1954 May;57(5):417–424. [PubMed] [Google Scholar]
- KELLNER A., CORRELL J. W., LADD A. T. Sustained hyperlipemia induced in rabbits by means of intravenously injected surface-active agents. J Exp Med. 1951 Apr 1;93(4):373–384. doi: 10.1084/jem.93.4.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KELLNER A., CORRELL J. W., LADD A. T. The influence of intravenously administered surface-active agents on the development of experimental atherosclerosis in rabbits. J Exp Med. 1951 Apr 1;93(4):385–398. doi: 10.1084/jem.93.4.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LEWIS L. A., GREEN A. A., PAGE I. H. Ultracentrifuge lipoprotein pattern of serum of normal, hypertensive and hypothyroid animals. Am J Physiol. 1952 Nov;171(2):391–400. doi: 10.1152/ajplegacy.1952.171.2.391. [DOI] [PubMed] [Google Scholar]
- LINDSAY S., FEINBERG H., CHAIKOFF I. L., ENTENMAN C., REICHERT F. L. Arteriosclerosis in the dog. II. Aortic, cardiac, and other vascular lesions in thyroidectomized hypophysectomized dogs. AMA Arch Pathol. 1952 Dec;54(6):573–591. [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- PATNODE R. A., HUDGINS P. C., JANICKI B. W. Studies on the effect of triton (WR-1339) on guinea pig tissues. I. Lipide chemistry of lung, liver, spleen, adrenals, and blood. J Exp Med. 1958 Jan 1;107(1):33–41. doi: 10.1084/jem.107.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PAYNE T. P. B., DUFF G. L. Effect of tween 80(R) on the serum lipids and the tissue of cholesterol-fed rabbits. AMA Arch Pathol. 1951 Apr;51(4):379–386. [PubMed] [Google Scholar]
- Parpart A. K., Lorenz P. B., Parpart E. R., Gregg J. R., Chase A. M. THE OSMOTIC RESISTANCE (FRAGILITY) OF HUMAN RED CELLS. J Clin Invest. 1947 Jul;26(4):636–640. doi: 10.1172/JCI101847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCANU A., ORIENTE P. Triton hyperlipemia in dogs. I. In vitro effects of the detergent on serum lipoproteins and chylomcrons. J Exp Med. 1961 Apr 1;113:735–757. doi: 10.1084/jem.113.4.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCHOTZ M. C., SCANU A., PAGE I. H. Effect of triton on lipoprotein lipase of rat plasma. Am J Physiol. 1957 Feb;188(2):399–402. doi: 10.1152/ajplegacy.1957.188.2.399. [DOI] [PubMed] [Google Scholar]
- SMITHIES O. Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults. Biochem J. 1955 Dec;61(4):629–641. doi: 10.1042/bj0610629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SPERRY W. M., WEBB M. A revision of the Schoenheimer-Sperry method for cholesterol determination. J Biol Chem. 1950 Nov;187(1):97–106. [PubMed] [Google Scholar]
- VAN HANDEL E., ZILVERSMIT D. B. Micromethod for the direct determination of serum triglycerides. J Lab Clin Med. 1957 Jul;50(1):152–157. [PubMed] [Google Scholar]
